These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31744155)

  • 61. Quinolinone and pyridopyrimidinone inhibitors of DNA-dependent protein kinase.
    Barbeau OR; Cano-Soumillac C; Griffin RJ; Hardcastle IR; Smith GC; Richardson C; Clegg W; Harrington RW; Golding BT
    Org Biomol Chem; 2007 Aug; 5(16):2670-7. PubMed ID: 18019542
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Modulating the cyclic guanosine monophosphate substrate selectivity of the phosphodiesterase 3 inhibitors by pyridine, pyrido[2,3-d]pyrimidine derivatives and their effects upon the growth of HT-29 cancer cell line.
    Abadi AH; Hany MS; Elsharif SA; Eissa AA; Gary BD; Tinsley HN; Piazza GA
    Chem Pharm Bull (Tokyo); 2013; 61(4):405-10. PubMed ID: 23546000
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Suzuki-Miyaura cross-coupling reactions of halo derivatives of 4H-pyrido[1,2-a]pyrimidin-4-ones.
    Molnár A; Kapros A; Párkányi L; Mucsi Z; Vlád G; Hermecz I
    Org Biomol Chem; 2011 Oct; 9(19):6559-65. PubMed ID: 21808806
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents.
    Vu CB; Luke GP; Kawahata N; Shakespeare WC; Wang Y; Sundaramoorthi R; Metcalf CA; Keenan TP; Pradeepan S; Corpuz E; Merry T; Bohacek RS; Dalgarno DC; Narula SS; van Schravendijk MR; Ram MK; Adams S; Liou S; Keats JA; Violette SM; Guan W; Weigele M; Sawyer TK
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3071-4. PubMed ID: 12941336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 1,2-fused pyrimidines. VI. Substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones with antiplatelet activity.
    Roma G; Di Braccio M; Leoncini G; Aprile B
    Farmaco; 1993 Sep; 48(9):1225-38. PubMed ID: 8259980
    [TBL] [Abstract][Full Text] [Related]  

  • 66. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
    Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
    J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Synthesis and analgesic activity of 3-substituted derivatives of pyrido [3',2':4,5]thieno[3,2-d]pyrimidin-4(3H)-ones].
    Bousquet E; Romeo G; Guerrera F; Caruso A; Amico-Roxas M
    Farmaco Sci; 1985 Nov; 40(11):869-74. PubMed ID: 4085646
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Synthesis and reactivity of debenzorutaecarpine derivatives].
    Kökösi J; Almási J; Kiss A; Forgó P; Böcskei Z; Fehér M; Hermecz I
    Acta Pharm Hung; 1999 Jun; 69(3):135-46. PubMed ID: 10401157
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A novel heterocyclic compound. Synthesis and reactivities of an oxazolo[3,2-a]thieno[3,2-d]-pyrimidine derivative.
    Fukumi H; Sugiyama M; Sakamoto T
    Chem Pharm Bull (Tokyo); 1989 May; 37(5):1197-200. PubMed ID: 2630087
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Why pyridine containing pyrido[2,3-d]pyrimidin-7-ones selectively inhibit CDK4 than CDK2: insights from molecular dynamics simulation.
    Mascarenhas NM; Bhattacharyya D; Ghoshal N
    J Mol Graph Model; 2010 Apr; 28(7):695-706. PubMed ID: 20153225
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recent developments regarding the use of thieno[2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties.
    Bozorov K; Zhao JY; Elmuradov B; Pataer A; Aisa HA
    Eur J Med Chem; 2015 Sep; 102():552-73. PubMed ID: 26312434
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nitrogen bridgehead compounds. 33. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. 2.
    Hermecz I; Breining T; Mészáros Z; Kökösi J; Mészáros L; Dessy F; DeVos C
    J Med Chem; 1983 Aug; 26(8):1126-30. PubMed ID: 6876080
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nitrogen bridgehead compounds. 38. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. 3.
    Hermecz I; Breining T; Vasvári-Debreczy L; Horváth A; Mészáros Z; Bitter I; DeVos C; Rodriguez L
    J Med Chem; 1983 Oct; 26(10):1494-9. PubMed ID: 6137567
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structure-activity relationship studies on the central 1,3-dioxoperhydropyrido[1,2-c]pyrimidine scaffold.
    Bartolomé-Nebreda JM; García-López MT; González-Muñiz R; Cenarruzabeitia E; Latorre M; Del Río J; Herranz R
    J Med Chem; 2001 Nov; 44(24):4196-206. PubMed ID: 11708921
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New 5H-[1,3]thiazolo[3,2-a]pyrido[3,2-e]pyrimidin-5-one derivatives as diuretics.
    Monge A; Martinez-Merino V; Simon MA; Sanmartin C
    Arzneimittelforschung; 1995 Mar; 45(3):306-10. PubMed ID: 7741791
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 1,6-Naphthyridin-2(1
    Oliveras JM; Puig de la Bellacasa R; Estrada-Tejedor R; Teixidó J; Borrell JI
    Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681253
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Syntheses and diuretic activity of 1,2-dihydro-2-(3-pyridyl)-3H-pyrido[2,3-d]pyrimidin-4-one and related compounds.
    Parish HA; Gilliom RD; Purcell WP; Browne RK; Spirk RF; White HD
    J Med Chem; 1982 Jan; 25(1):98-102. PubMed ID: 7086830
    [No Abstract]   [Full Text] [Related]  

  • 78. Recent developments in the synthesis and applications of dihydropyrimidin-2(1H)-ones and thiones.
    Mohammadi B; Behbahani FK
    Mol Divers; 2018 May; 22(2):405-446. PubMed ID: 29349521
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Regioselective C3 alkenylation of 4 H-pyrido[1,2-a]pyrimidin-4-ones via palladium-catalyzed C-H activation.
    Liu W; Wang S; Zhang Q; Yu J; Li J; Xie Z; Cao H
    Chem Asian J; 2014 Sep; 9(9):2436-9. PubMed ID: 24990766
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Auto-tandem catalysis: synthesis of 4H-pyrido[1,2-a]pyrimidin-4-ones via copper-catalyzed aza-Michael addition-aerobic dehydrogenation-intramolecular amidation.
    Yang Y; Shu WM; Yu SB; Ni F; Gao M; Wu AX
    Chem Commun (Camb); 2013 Feb; 49(17):1729-31. PubMed ID: 23340739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.